KP
Kannasandra Pushpalatha
About Kannasandra Pushpalatha
Data last updated:
Kannasandra Pushpalatha is a Director at Vipragen Biosciences Private Limited (since 2014), Director at Glogene Bio Private Limited (since 2025) and Director at Cypa Therapeutics Private Limited (since 2022). The companies operate in Pharma, Research & Development and E-Commerce. The largest current company by reported revenue is Vipragen Biosciences Private Limited at ₹18.35 Cr (FY 2025). Earlier, Kannasandra Pushpalatha was a Director at Genei Laboratories Private Limited (2015–2020) and Director at Enzene Biosciences Limited (2006–2011).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Jul 2014 | 2012 | ₹18.35 Cr (FY 2025) | Active | |
| Director | 03 Apr 2025 | 2025 | Active | ||
| Director | 06 Jun 2022 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Dec 2015 | 2013 | ₹9.23 Cr (FY 2026) | Active | |
| Director | 28 Aug 2006 | 2006 | ₹385 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kannasandra Pushpalatha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pallavur Viswanathan Harikrishnan | 10339546 | Vipragen Biosciences Private Limited | Nominee Director |
| Patlapati Harsha Samaraditya | 11266474 | Vipragen Biosciences Private Limited | Additional Director |
| Siddamadappa Chandrashekaran | 01770678 | Vipragen Biosciences Private Limited | Managing Director |
| Umesh Devurkar | 06382944 | Vipragen Biosciences Private Limited | Director |
| Yashas | 08817972 | Vipragen Biosciences Private Limited , Cypa Therapeutics Private Limited | Director |
| Suman Vijay Ambati | 03177651 | Glogene Bio Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kannasandra Pushpalatha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kannasandra Pushpalatha
Kannasandra Pushpalatha currently holds 3 directorships: Vipragen Biosciences Private Limited (Director, since 01 Jul 2014, revenue ₹18.35 Cr (FY 2025)); Glogene Bio Private Limited (Director, since 03 Apr 2025); Cypa Therapeutics Private Limited (Director, since 06 Jun 2022).
Kannasandra Pushpalatha was first appointed on 28 Aug 2006 as Director at Enzene Biosciences Limited. The most recent appointment on record is 03 Apr 2025 at Glogene Bio Private Limited.
Kannasandra Pushpalatha held 2 earlier board appointments: Genei Laboratories Private Limited (Director, 10 Dec 2015 to 21 Nov 2020); Enzene Biosciences Limited (Director, 28 Aug 2006 to 01 Dec 2011).
The current boards of Kannasandra Pushpalatha's companies include Pallavur Viswanathan Harikrishnan (Vipragen Biosciences Private Limited), Patlapati Harsha Samaraditya (Vipragen Biosciences Private Limited), Siddamadappa Chandrashekaran (Vipragen Biosciences Private Limited), Umesh Devurkar (Vipragen Biosciences Private Limited), Yashas (Vipragen Biosciences Private Limited), Suman Vijay Ambati (Glogene Bio Private Limited).